Overview
Kniest dysplasia (also known as Kniest syndrome or metatropic dwarfism type II) is a rare skeletal disorder belonging to the group of type II collagenopathies. It is caused by mutations in the COL2A1 gene, which encodes type II collagen, a critical structural protein found in cartilage, the vitreous humor of the eye, and the inner ear. The condition is characterized by disproportionate short stature (short trunk dwarfism), a flat face with prominent eyes, enlarged and stiff joints (particularly the knees), and a short trunk with kyphoscoliosis. Skeletal abnormalities are typically apparent at birth, with affected individuals often presenting with a short trunk, shortened limbs, and a characteristic "Swiss cheese" appearance of cartilage on histological examination. Kniest dysplasia affects multiple body systems beyond the skeleton. Ocular complications are common and include severe myopia, vitreoretinal degeneration, and retinal detachment, which can lead to significant visual impairment or blindness if untreated. Sensorineural and/or conductive hearing loss is frequently observed and may be progressive. Affected individuals may also experience recurrent otitis media, cleft palate, and respiratory difficulties in infancy due to tracheomalacia or a small chest. Joint contractures and progressive joint enlargement can significantly limit mobility, and early-onset osteoarthritis is common. Intelligence is typically normal. There is currently no cure for Kniest dysplasia, and management is supportive and multidisciplinary. Treatment focuses on orthopedic interventions for joint contractures and skeletal deformities, ophthalmologic monitoring and treatment to prevent vision loss, audiologic assessment and hearing aids as needed, and management of respiratory complications. Physical therapy plays an important role in maintaining joint mobility. Regular surveillance by a team including orthopedists, ophthalmologists, audiologists, and pulmonologists is recommended to address complications as they arise.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Kniest dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Kniest dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Kniest dysplasia.
Community
No community posts yet. Be the first to share your experience with Kniest dysplasia.
Start the conversation →Latest news about Kniest dysplasia
No recent news articles for Kniest dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Kniest dysplasia
What is Kniest dysplasia?
Kniest dysplasia (also known as Kniest syndrome or metatropic dwarfism type II) is a rare skeletal disorder belonging to the group of type II collagenopathies. It is caused by mutations in the COL2A1 gene, which encodes type II collagen, a critical structural protein found in cartilage, the vitreous humor of the eye, and the inner ear. The condition is characterized by disproportionate short stature (short trunk dwarfism), a flat face with prominent eyes, enlarged and stiff joints (particularly the knees), and a short trunk with kyphoscoliosis. Skeletal abnormalities are typically apparent at
How is Kniest dysplasia inherited?
Kniest dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Kniest dysplasia typically begin?
Typical onset of Kniest dysplasia is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Kniest dysplasia?
1 specialists and care centers treating Kniest dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.